These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

537 related articles for article (PubMed ID: 7915708)

  • 21. "As needed" pharmacotherapy combined with stimulus control treatment in chronic insomnia--assessment of a novel intervention strategy in a primary care setting.
    Hajak G; Bandelow B; Zulley J; Pittrow D
    Ann Clin Psychiatry; 2002 Mar; 14(1):1-7. PubMed ID: 12046635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ramelteon for the treatment of insomnia.
    Borja NL; Daniel KL
    Clin Ther; 2006 Oct; 28(10):1540-55. PubMed ID: 17157111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Benzodiazepines for insomnia in community-dwelling elderly: a review of benefit and risk.
    Grad RM
    J Fam Pract; 1995 Nov; 41(5):473-81. PubMed ID: 7595266
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and tolerability of modified-release indiplon in elderly patients with chronic insomnia: results of a 2-week double-blind, placebo-controlled trial.
    Lydiard RB; Lankford DA; Seiden DJ; Landin R; Farber R; Walsh JK
    J Clin Sleep Med; 2006 Jul; 2(3):309-15. PubMed ID: 17561543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quazepam for insomnia.
    Blake GJ
    Nursing; 1991 Apr; 21(4):118. PubMed ID: 2020409
    [No Abstract]   [Full Text] [Related]  

  • 26. Efficacy and tolerability of indiplon in older adults with primary insomnia.
    Walsh JK; Moscovitch A; Burke J; Farber R; Roth T
    Sleep Med; 2007 Nov; 8(7-8):753-9. PubMed ID: 17825616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia.
    Scharf MB; Roth T; Vogel GW; Walsh JK
    J Clin Psychiatry; 1994 May; 55(5):192-9. PubMed ID: 8071269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlates and consequences of chronic insomnia.
    Thase ME
    Gen Hosp Psychiatry; 2005; 27(2):100-12. PubMed ID: 15763121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Eight weeks of non-nightly use of zolpidem for primary insomnia.
    Walsh JK; Roth T; Randazzo A; Erman M; Jamieson A; Scharf M; Schweitzer PK; Ware JC
    Sleep; 2000 Dec; 23(8):1087-96. PubMed ID: 11145323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Main neuroendocrine features and therapy in primary sleep troubles.
    Amihăesei IC; Mungiu OC
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(3):862-6. PubMed ID: 23272543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypnotic effects of low doses of quazepam in older insomniacs.
    Roth TG; Roehrs TA; Koshorek GL; Greenblatt DJ; Rosenthal LD
    J Clin Psychopharmacol; 1997 Oct; 17(5):401-6. PubMed ID: 9315991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An evaluation of the efficacy and safety of eszopiclone over 12 months in patients with chronic primary insomnia.
    Roth T; Walsh JK; Krystal A; Wessel T; Roehrs TA
    Sleep Med; 2005 Nov; 6(6):487-95. PubMed ID: 16230048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Eszopiclone, a nonbenzodiazepine sedative-hypnotic agent for the treatment of transient and chronic insomnia.
    Najib J
    Clin Ther; 2006 Apr; 28(4):491-516. PubMed ID: 16750462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Short-term sleep laboratory studies with cinolazepam in situational insomnia induced by traffic noise.
    Saletu B; Kindshofer G; Anderer P; Grünberger J
    Int J Clin Pharmacol Res; 1987; 7(5):407-18. PubMed ID: 2889679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The influence of co-morbidities on prescribing pharmacotherapy for insomnia: evidence from US national outpatient data 1995-2004.
    Pawaskar MD; Joish VN; Camacho FT; Rasu RS; Balkrishnan R
    J Med Econ; 2008; 11(1):41-56. PubMed ID: 19450109
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pharmacologic treatment of insomnia in children and adolescent psychiatric patients].
    Chevreuil C; Polard E; Gicquel G; Frémaux T; Bentué-Ferrer D;
    Therapie; 2010; 65(1):1-12. PubMed ID: 20205989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A postmarketing surveillance study of zopiclone in insomnia.
    Mahendran R; Chee KT; Peh LH; Wong KE; Lim L
    Singapore Med J; 1994 Aug; 35(4):390-3. PubMed ID: 7899899
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of placebo administration on the first-night effect in healthy young volunteers.
    Suetsugi M; Mizuki Y; Yamamoto K; Uchida S; Watanabe Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 May; 31(4):839-47. PubMed ID: 17328999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A polysomnography study of eszopiclone in elderly patients with insomnia.
    McCall WV; Erman M; Krystal AD; Rosenberg R; Scharf M; Zammit GK; Wessel T
    Curr Med Res Opin; 2006 Sep; 22(9):1633-42. PubMed ID: 16968566
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the short-term treatment of insomnia in out-patients with 15 milligrams of quazepam.
    Mendels J; Stern S
    J Int Med Res; 1983; 11(3):155-61. PubMed ID: 6347747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.